Tigen Pharma is a Swiss biotech company that serves as the catalyst in the cell and gene therapy ecosystem. Our vision is to accelerate the access to groundbreaking therapies for patients and society. We achieve this by scouting for disruptive ideas, combining them with state-of-the-art clinical, process, and technology expertise, and partnering for commercialization.

Our unique Catalyst Model bridges the gap between academia and commercially ready therapies. We collaborate with academia early on to bring innovative science onto our cutting-edge manufacturing platform, expediting the transfer from pre-clinical studies to safety, efficacy, and registration studies. Additionally, we forge partnerships with regional and global institutions for market and patient access.

As a highly networked company, we have a core team of experienced cell and gene experts working hand in hand to develop breakthrough ideas. Our engagement principles, including curiosity, collaboration, excellence, and agility, guide us in pushing the boundaries of innovation.

We believe in the importance of sustainability and align ourselves with the United Nations Sustainable Development Goals. Through our multidisciplinary team and disruptive approach, we strive to improve both the ecological and social sustainability of the cell and gene ecosystem.

By supporting charitable initiatives related to science and education, as well as humanitarian, health, and social causes, we actively give back to society.

Join us in shaping the future of cell and gene therapy. Visit our office and laboratory in Switzerland or contact us via email. Tigen Pharma is your partner in accelerating the transfer of breakthrough science to the patient.